Left ventricular dyssynchrony in patients with heart failure: pathophysiology, diagnosis and treatment
- PMID: 16568130
- DOI: 10.1038/ncpcardio0505
Left ventricular dyssynchrony in patients with heart failure: pathophysiology, diagnosis and treatment
Abstract
The number of patients with chronic heart failure is increasing rapidly in the Western world. Despite the introduction of new pharmacologic therapies, the prognosis of these patients remains poor. Left ventricular (LV) dyssynchrony is a frequently observed feature in patients with heart failure, and is recognized as an important predictor of poor outcome if left untreated. The presence of LV dyssynchrony leads to inefficient LV contraction with a decreased cardiac output. Moreover, patients with LV dyssynchrony are at increased risk of adverse cardiac events. New therapeutic options targeted at restoring normal mechanical synchrony, such as cardiac resynchronization therapy, have been shown to improve clinical symptoms and prognosis in patients with heart failure. The beneficial effects of cardiac resynchronization therapy are predominantly mediated by this treatment's ability to reduce LV dyssynchrony. Given these results, adequate identification of LV dyssynchrony in patients with heart failure is of paramount importance. Several new imaging techniques are proving useful for diagnosis of LV dyssynchrony. In particular, advanced echocardiographic techniques (e.g. tissue Doppler imaging) and conductance catheter techniques are two accurate methods for quantification of LV dyssynchrony. In this review, we discuss the pathophysiology, diagnosis and treatment of LV dyssynchrony in patients with heart failure.
Similar articles
-
Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.Am J Cardiol. 2009 May 1;103(9):1280-4. doi: 10.1016/j.amjcard.2009.01.023. Am J Cardiol. 2009. PMID: 19406272
-
Cardiac resynchronization therapy in patients with a narrow QRS complex.J Am Coll Cardiol. 2006 Dec 5;48(11):2243-50. doi: 10.1016/j.jacc.2006.07.067. Epub 2006 Nov 9. J Am Coll Cardiol. 2006. PMID: 17161254 Clinical Trial.
-
Severe left ventricular dyssynchrony is associated with poor prognosis in patients with moderate systolic heart failure undergoing coronary artery bypass grafting.J Am Coll Cardiol. 2007 Oct 2;50(14):1315-23. doi: 10.1016/j.jacc.2007.03.070. Epub 2007 Sep 17. J Am Coll Cardiol. 2007. PMID: 17903629
-
Cardiac resynchronization therapy or atrio-biventricular pacing-what should it be called?Nat Clin Pract Cardiovasc Med. 2007 Feb;4(2):90-101. doi: 10.1038/ncpcardio0794. Nat Clin Pract Cardiovasc Med. 2007. PMID: 17245403 Review.
-
Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?Interact Cardiovasc Thorac Surg. 2008 Dec;7(6):1141-6. doi: 10.1510/icvts.2008.183707. Epub 2008 Jun 9. Interact Cardiovasc Thorac Surg. 2008. PMID: 18541605 Review.
Cited by
-
Heart Failure and Wide QRS: Clinical and Pharmacological Perspectives.Biomedicines. 2025 Jun 13;13(6):1462. doi: 10.3390/biomedicines13061462. Biomedicines. 2025. PMID: 40564182 Free PMC article. Review.
-
A computational approach to understanding the cardiac electromechanical activation sequence in the normal and failing heart, with translation to the clinical practice of CRT.Prog Biophys Mol Biol. 2012 Oct-Nov;110(2-3):372-9. doi: 10.1016/j.pbiomolbio.2012.07.009. Epub 2012 Aug 1. Prog Biophys Mol Biol. 2012. PMID: 22884712 Free PMC article. Review.
-
Cardiac remodeling and arrhythmogenesis are ameliorated by administration of Cx43 mimetic peptide Gap27 in heart failure rats.Sci Rep. 2020 Apr 23;10(1):6878. doi: 10.1038/s41598-020-63336-6. Sci Rep. 2020. PMID: 32327677 Free PMC article.
-
Beta Blockers Up-Titration in Patients with Heart Failure Reduced Ejection Fraction and Cardiac Resynchronization Therapy, a Single Center Study.Med Sci (Basel). 2019 Jun 18;7(6):71. doi: 10.3390/medsci7060071. Med Sci (Basel). 2019. PMID: 31216616 Free PMC article.
-
Parathyroid suppression therapy normalizes chronic kidney disease-induced elevations in cortical bone vascular perfusion: a pilot study.Osteoporos Int. 2019 Aug;30(8):1693-1698. doi: 10.1007/s00198-019-04974-z. Epub 2019 May 8. Osteoporos Int. 2019. PMID: 31069439 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical